Renin-angiotensin system: Upgrade of recent knowledge and perspectives

Endocrine Regulations

Volumn 47, Issue 1, 2013, Pages 39-52

  Herichova, I ^a   Szantoova, K ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Angiotensin; Angiotensin AT1 receptors; Angiotensin converting enzyme; Angiotensin converting enzyme 2; Experimental model

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN [1-7]; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSINOGEN; CATHEPSIN G; CHYMASE; COLLAGEN TYPE 5; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMYL AMINOPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; NATRIURETIC FACTOR; NORADRENALIN; PRORENIN; RENIN; SOMATOMEDIN B RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN RECEPTOR;

ARTICLE; BLOOD PRESSURE; BRAIN; GENE EXPRESSION; HEART; HEART HYPERTROPHY; HUMAN; NONHUMAN; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BLOOD; ENDOCRINOLOGY; GENETICS; METABOLISM; METHODOLOGY; REVIEW; TISSUE DISTRIBUTION;

ANGIOTENSINS; ANIMALS; ENDOCRINOLOGY; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ANGIOTENSIN; RENIN; RENIN-ANGIOTENSIN SYSTEM; TISSUE DISTRIBUTION;

MLCS; MLOWN;

EID: 84877334814     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2013_01_39     Document Type: Article

References (72)

1. Bader M: Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 50, 439-465, 2010. http://dx.doi.org/10.1146/annurev.pharmtox.010909.105610
2. Bader M, Ganten D: Update on tissue rennin-angiotensin systems. J Mol Med 86, 615-621, 2008. http://dx.doi.org/10.1007/s00109-008-0336-0
3. Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D, Bader M: Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen. Hypertension 37, 408-413, 2001. http://dx.doi.org/10.1161/01.HyP.37.2.408
4. Baltatu OC, Campos LA, Bader M: Local renin-angiotensin system and the brain--a continuous quest for knowledge. Peptides 32, 1083-1086, 2011. http://dx.doi.org/10.1016/j.peptides.2011.02.008
5. Bennett JP Jr, Snyder SH: Angiotensin II binding to mammalian brain membranes. J Biol Chem 251, 7423-7430, 1976.
6. Bermann MA, Walsh MF, Sowers JS: Angiotensin-II Biochemistry and Physiology: Update on Angiotensin-I1 Receptor Blockers: Cardiovasc Drug Rev 15, 75-100, 2007. http://dx.doi.org/10.1111/j.1527-3466.1997.tb00325.x
7. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H: Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 4, 966-972, 1982. http://dx.doi.org/10.1097/00005344-198211000-00014
8. Brasch H, Sieroslawski L, Dominiak P: Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension. 22, 699-704, 1993. http://dx.doi.org/10.1161/01.HyP.22.5.699
9. Bright R: Tabular view of the morbid appearances in 100 cases connected with albuminous urine: with observations. Guy's Hosp Rep 1, 380-400, 1836.
10. Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL: Te angiotensin IV/AT4 receptor. Cell Mol Life Sci 61, 2728-2737, 2004. http://dx.doi.org/10.1007/s00018-004-4246-1
11. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Grifths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Cofman TM: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115, 1092-1099, 2005.
12. Cugini P, Lucia P: Circadian rhythm of the renin-angiotensin-aldosterone system: a summary of our research studies. Clin Ter 155, 287-291, 2004.
13. Cummins PM: A new addition to the renin-angiotensin peptide family: proAngiotensin-12 (PA12). Cardiovasc Res 82, 7-8, 2009. http://dx.doi.org/10.1093/cvr/cvp053
14. Danser AH: Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 35, 759-768, 2003. http://dx.doi.org/10.1016/S1357-2725(02)00178-4 De
15. Mello WC: Cardiac intracrine renin angiotensin system. Part of genetic reprogramming? Regul Pept 133, 10-12, 2006. http://dx.doi.org/10.1016/j.regpep.2005.09.020
16. De Mello WC, Frohlich ED: On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides 32, 1774-1779, 2011. http://dx.doi.org/10.1016/j.peptides.2011.06.018
17. de Mota N, Iturrioz X, Claperon C, Bodineau L, Fassot C, Roques BP, Palkovits M, Llorens-Cortes C: Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei. J Neurochem 106, 416-428, 2008. http://dx.doi.org/10.1111/j.1471-4159.2008.05402.x
18. Dinh DT, Frauman AG, Johnston CI, Fabiani ME: Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) 100, 481-492, 2001. http://dx.doi.org/10.1042/CS20000263
19. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87, E1-E9, 2000. http://dx.doi.org/10.1161/01.RES.87.5.e1
20. Ferrario CM, Trask AJ, Jessup JA: Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289, H2281-2290, 2005. http://dx.doi.org/10.1152/ajpheart.00618.2005
21. Ferro CJ, Spratt JC, Haynes WG, Webb DJ: Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation 97, 2323-2330, 1998. http://dx.doi.org/10.1161/01.CIR.97.23.2323
22. Fruhbeck G: Te adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2, 197-208, 2004. http://dx.doi.org/10.2174/1568016043356255
23. Fyhrquist F, Saijonmaa O: Renin-angiotensin system revisited. J Intern Med 264, 224-236, 2008. http://dx.doi.org/10.1111/ j.1365-2796.2008.01981.x
24. Ganten D, Hayduk K, Brecht HM, Boucher R, Genest J: Evidence of renin release or production in splanchnic territory. Nature 226, 551-552, 1970. http://dx.doi.org/10.1038/226551a0
25. Ganten D, Ganten U, Schelling P, Boucher R, Genest J: Te renin and isorenin-angiotensin system in rats with experimental pitutary tumors (38585). Proc Soc Exp Biol Med 148, 568-572, 1975.
26. Goldblatt H, Lynch J, Hanzal RF, Summerville WW: Studies on experimental hypertension, I: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59, 347-379, 1934. http://dx.doi.org/10.1084/jem.59.3.347
27. Gurley SB, Allred A, Le TH, Grifths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL, Rockman HA, Cofman TM: Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116, 2218-2225, 2006. http://dx.doi.org/10.1172/JCI16980
28. Hata A: Role of angiotensinogen in the genetics of essential hypertension. Life Sci 57, 2385-2395, 1995. http://dx.doi. org/10.1016/0024-3205(95)02175-8
29. Huskova Z, Kramer H, Vanourkova Z, Tumova M, Maly J, Opocensky M, Skaroupkova P, Kolsky A, Vernerova Z, Cervenka L: Efects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats. Kidney Blood Press Res 30, 45-55, 2007. http://dx.doi.org/10.1159/000099028
30. Imai T, Miyazaki H, Hirose S, Hori H, Hayashi T, Kageyama R, Ohkubo H, Nakanishi S, Murakami K: Cloning and sequence analysis of cDNA for human renin precursor. Proc Natl Acad Sci U S A 80, 7405-7409, 1983. http://dx.doi.org/10.1073/pnas.80.24.7405
31. Jurkovicova D, Dobesova Z, Kunes J, Krizanova O: Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats. Physiol Res 50, 35-42, 2001.
32. Krskova K, Filipcik P, Zilka N, Olszanecki R, Korbut R, Gajdosechova L, Zorad S: Angiotensinogen and angiotensinconverting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferatoractivated receptor (PPARγ). J Physiol Pharmacol 62, 403-410, 2011.
33. Kumar R, Singh V P, Baker KM: Te intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens 17, 168-173, 2008. http://dx.doi.org/10.1097/MNH.0b013e3282f521a8
34. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J: Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics 18, 152-166, 2004. http://dx.doi.org/10.1152/physiolgenomics.00057.2004
35. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Endocrinology 144, 2179-2183, 2003. http://dx.doi.org/10.1210/en.2003-0150
36. Lazartigues E, Feng y, Lavoie JL: Te two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Curr Pharm Des 13, 1231-1245, 2007. http://dx.doi.org/10.2174/138161207780618911
37. Lemarie CA, Schifrin EL: Te angiotensin II type 2 receptor in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 11, 19-31, 2010. http://dx.doi.org/10.1177/1470320309347785
38. Marks LS, Maxwell MH: Tigerstedt and the discovery of renin. An historical note. Hypertension 4, 384-388, 1979. http://dx.doi.org/10.1161/01.HyP.1.4.384
39. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfeld BJ, Mendelsohn FA, Chai SY: Te brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35, 901-918, 2003. http://dx.doi.org/10.1016/S1357-2725(02)00306-0
40. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292, C82-97, 2007. http://dx.doi.org/10.1152/ajpcell.00287.2006
41. Mentlein R: Cell-surface peptidases. Int Rev Cytol 235, 165-213, 2004. http://dx.doi.org/10.1016/S0074-7696(04)350047
42. Moniwa N, Varagic J, Ahmad S, VonCannon JL, Ferrario CM: Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats. Ter Adv Cardiovasc Dis 6, 15-29, 2012. http://dx.doi.org/10.1177/1753944711434039
43. Monosikova J, Herichova I, Mravec B, Kiss A, Zeman M: Effect of upregulated renin-angiotensin system on per2 and bmal1 gene expression in brain structures involved in blood pressure control in TGR(mREN-2)27 rats. Brain Res 1180, 29-38, 2007. http://dx.doi.org/10.1016/j.brainres.2007.08.061
44. Monosikova J, Zeman M, Vesela A, Herichova I: Down regulation of angiotensin II receptor AT1 expression in the pancreas of diabetic rat. Exp Clin Endocrinol Diabetes 117, 438-439, 2009. http://dx.doi.org/10.1055/s-0029-1216376
45. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344, 541-544, 1990. http://dx.doi.org/10.1038/344541a0
46. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351, 233-236, 1991. http://dx.doi.org/10.1038/351233a0
47. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K: Isolation and identifcation of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 350, 1026-1031, 2006. http://dx.doi.org/10.1016/j.bbrc.2006.09.146
48. Navar LG, Zou L, Von Tun A, Tarng Wang C, Imig JD, Mitchell KD: Unraveling the Mystery of Goldblatt Hypertension. News Physiol Sci 13, 170-176, 1998.
49. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S: Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci U S A 80, 2196-2200, 1983. http://dx.doi.org/10.1073/pnas.80.8.2196
50. Okamura T, Clemens DL, Inagami T: Renin, angiotensins, and angiotensin-converting enzyme in neuroblastoma cells: evidence for intracellular formation of angiotensins. Proc Natl Acad Sci U S A 78, 6940-6943, 1981. http://dx.doi.org/10.1073/pnas.78.11.6940
51. Padia SH, Kemp BA, Howell NL, Fournie-Zaluski MC, Roques B P, Carey RM: Conversion of renal angiotensin II to angiotensin III is critical for AT2 Hypertension 51, 460-465, 2008.
52. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 86, 747-803, 2006. http://dx.doi.org/10.1152/physrev.00036.2005
53. Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R: Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J Mol Cell Cardiol 41, 459-466, 2006. http://dx.doi.org/10.1016/j.yjmcc.2006.06.004
54. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, Chappell MC: Diferential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol 290, F1497F1506, 2006. http://dx.doi.org/10.1152/ajprenal.00317.2005
55. Peters J: Secretory and cytosolic (pro)renin in kidney, heart, and adrenal gland. J Mol Med (Berl) 86, 711-714 2008. http://dx.doi.org/10.1007/s00109-008-0328-0
56. Phillips MI, de Oliveira EM: Brain renin angiotensin in disease. J Mol Med (Berl) 86, 715-722, 2008. http://dx.doi.org/10.1007/s00109-008-0331-5
57. Saavedra JM, Sanchez-Lemus E, Benicky J: Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36, 1-18, 2011. http://dx.doi.org/10.1016/j.psyneuen.2010.10.001
58. Sasaki K, yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351, 230-233, 1991. http://dx.doi.org/10.1038/351230a0
59. Schiavone MT, Santos RA, Brosnihan KB, Khosla MC, Ferrario CM: Release of vasopressin from the rat hypothalamoneurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A 85, 4095-4098, 1988. http://dx.doi.org/10.1073/pnas.85.11.4095
60. Schifer S, Pummer S, Witte K, Lemmer B: Cardiovascular regulation in TGR(mREN2)27 rats: 24h variation in plasma catecholamines, angiotensin peptides, and telemetric heart rate variability. Chronobiol Int 18, 461-474, 2001. http://dx.doi.org/10.1081/CBI-100103969
61. Schifrin EL, Gutkowska J, Genest J: Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am J Physiol 246, H608-H614, 1984.
62. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M: Blood pressure reduction and diabetes insipidus in transgenic rats defcient in brain angiotensinogen. Proc Natl Acad Sci U S A 96, 3975-3980, 1999. http://dx.doi.org/10.1073/pnas.96.7.3975
63. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: Renin-angiotensin system and cardiovascular risk. Lancet 369, 1208-1219, 2007. http://dx.doi.org/10.1016/S0140-6736(07)60242-6
64. Schwartz F, Duka A, Duka I, Cui J, Gavras H: Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression. Am J Physiol Heart Circ Physiol 287, H1957-H1966, 2004. http://dx.doi.org/10.1152/ajpheart.00568.2004
65. Semple PF, Boyd AS, Dawes PM, Morton JJ: Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res 39, 671-678, 1976. http://dx.doi.org/10.1161/01.RES.39.5.671
66. Skeggs LT Jr, Marsh WH, Kahn JR, Shumway NP: Te existence of two forms of hypertensin. J Exp Med 99, 275-282, 1954. http://dx.doi.org/10.1084/jem.99.3.275
67. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A 85, 9386-9390. 1988. http://dx.doi.org/10.1073/pnas.85.24.9386
68. Soucek M, Kara T: Klinicka patofyziologie hypertenze, Grada publishing s.r.o., Praha, 2002. Szantoova K: Te regulation of peripheral oscillators in conditions of internal desynchronization. Dissertation thesis, Comenius University Bratislava, 2012.
69. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275, 33238-33243, 2000. http://dx.doi.org/10.1074/jbc.M002615200
70. van Kesteren CA, Danser AH, Derkx FH, Dekkers DH, Lamers JM, Saxena PR, Schalekamp MA: Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 30, 1389-1396, 1997. http://dx.doi.org/10.1161/01.HyP.30.6.1389
71. Wallace KB, Oparil S, Bailie MD: Angiotensin II metabolism by tissues from developing rats. Pediatr Res 15, 1088-1092, 1981. http://dx.doi.org/10.1203/00006450-198108000-00003
72. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG: Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39, 116-121, 2002. http://dx.doi.org/10.1161/hy0102.100780